Search research articles
Contact Us
Filters
Showing results (81-90 of 151) with videos related to
Page
of 16
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
November 21, 2021
The Lipopolysaccharide Mutant Re-LPS Is a Useful Tool for Detecting LPS Contamination in Rheumatoid Synovial Cell Cultures
Hiroki Kohno, Kazuhisa Ouhara, Sho Mokuda, et al.
Internal Medicine (Tokyo, Japan)
|
June 26, 2020
Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
Yu Nakanishi, Kakuhiro Yamaguchi, Yusuke Yoshida, et al.
Rheumatology (Oxford, England)
|
November 5, 2024
Predictors of the effectiveness of first-line CTLA4-Ig in patients with RA: the FIRST registry
Hiroki Kobayashi, Yusuke Miyazaki, Shingo Nakayamada, et al.
Annals of the Rheumatic Diseases
|
June 2, 2018
Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study)
Yuko Kaneko, Masaru Kato, Yoshiya Tanaka, et al.
Modern Rheumatology
|
August 25, 2023
Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational 'ORIGAMI' study
Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, et al.
Annals of the Rheumatic Diseases
|
January 7, 2016
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)
Yuko Kaneko, Tatsuya Atsumi, Yoshiya Tanaka, et al.
Lupus Science & Medicine
|
January 20, 2025
Impact of quality of life on overall work productivity impairment and activity impairment of patients with systemic lupus erythematosus: the PEONY study
Yoshiya Tanaka, Yusuke Miyazaki, Shintaro Hirata, et al.
The Journal of Dermatology
|
April 13, 2021
The clinical characteristics and predictors of severe digital ischemia in patients with anti-aminoacyl transfer RNA synthetase antibodies
Harumichi Suma, Yusuke Yoshida, Tomohiro Sugimoto, et al.
Modern Rheumatology
|
November 7, 2024
Safety and efficacy of filgotinib in Japanese patients with rheumatoid arthritis: Week 156 interim results in FINCH 4
Yoshiya Tanaka, Tsukasa Matsubara, Tatsuya Atsumi, et al.
Modern Rheumatology
|
December 11, 2025
Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study
Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 151) with videos related to
Sort By:
Page
of 16
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
November 21, 2021
The Lipopolysaccharide Mutant Re-LPS Is a Useful Tool for Detecting LPS Contamination in Rheumatoid Synovial Cell Cultures
Hiroki Kohno, Kazuhisa Ouhara, Sho Mokuda, et al.
Internal Medicine (Tokyo, Japan)
|
June 26, 2020
Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
Yu Nakanishi, Kakuhiro Yamaguchi, Yusuke Yoshida, et al.
Rheumatology (Oxford, England)
|
November 5, 2024
Predictors of the effectiveness of first-line CTLA4-Ig in patients with RA: the FIRST registry
Hiroki Kobayashi, Yusuke Miyazaki, Shingo Nakayamada, et al.
Annals of the Rheumatic Diseases
|
June 2, 2018
Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study)
Yuko Kaneko, Masaru Kato, Yoshiya Tanaka, et al.
Modern Rheumatology
|
August 25, 2023
Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational 'ORIGAMI' study
Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, et al.
Annals of the Rheumatic Diseases
|
January 7, 2016
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)
Yuko Kaneko, Tatsuya Atsumi, Yoshiya Tanaka, et al.
Lupus Science & Medicine
|
January 20, 2025
Impact of quality of life on overall work productivity impairment and activity impairment of patients with systemic lupus erythematosus: the PEONY study
Yoshiya Tanaka, Yusuke Miyazaki, Shintaro Hirata, et al.
The Journal of Dermatology
|
April 13, 2021
The clinical characteristics and predictors of severe digital ischemia in patients with anti-aminoacyl transfer RNA synthetase antibodies
Harumichi Suma, Yusuke Yoshida, Tomohiro Sugimoto, et al.
Modern Rheumatology
|
November 7, 2024
Safety and efficacy of filgotinib in Japanese patients with rheumatoid arthritis: Week 156 interim results in FINCH 4
Yoshiya Tanaka, Tsukasa Matsubara, Tatsuya Atsumi, et al.
Modern Rheumatology
|
December 11, 2025
Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study
Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, et al.
Page
of 16